These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32301714)

  • 1. Pustular psoriasis with severe liver dysfunction: psoriasis-specific immune hepatitis?
    Yamazaki Y; Matsuo S; Ishikawa T; Munetsugu T; Nishizawa A; Fujimoto N; Satoh T
    Eur J Dermatol; 2021 Apr; 31(2):277-279. PubMed ID: 32301714
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab.
    Nagata M; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Sugiura K; Tada Y
    J Am Acad Dermatol; 2020 Mar; 82(3):758-761. PubMed ID: 31560979
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical therapy for psoriasis.
    Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
    Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab.
    Mössner R; Reich K
    Curr Probl Dermatol; 2009; 38():107-136. PubMed ID: 19710553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Use of Secukinumab in Various Scenarios of Psoriasis.
    Chhabra G; Verma P; Khunger N
    Skinmed; 2020; 18(5):274-276. PubMed ID: 33160436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Autoimmune Hepatitis during Brodalumab Treatment for Psoriasis.
    Serizawa N; Hoashi T; Saeki H; Kanda N
    J Nippon Med Sch; 2020; 87(6):359-361. PubMed ID: 33431762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
    Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
    J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of secukinumab in psoriasis patients with latent tuberculosis infection.
    Machado Á; Abreu M; Torres T
    Eur J Dermatol; 2020 Dec; 30(6):740-741. PubMed ID: 33237033
    [No Abstract]   [Full Text] [Related]  

  • 9. Good efficacy and tolerability of ustekinumab in a patient with severe psoriasis under haemodialysis.
    Larquey M; Poreaux C; Cuny JF; Barbaud A; Schmutz JL
    Eur J Dermatol; 2014; 24(5):618-9. PubMed ID: 25445092
    [No Abstract]   [Full Text] [Related]  

  • 10. Recalcitrant psoriasis responding to new bilogic drug: ustekinumab.
    Husein-ElAhmed H; Molina-Leyva A; Garrido-TorresPuchol V; Ruiz-Carrascosa J
    Ann Saudi Med; 2013; 33(6):632-3. PubMed ID: 24413873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions].
    Piqueras M; Monfort D; Pol MA; Galter S; Modolell I; Ortiz J; Boadas J
    Gastroenterol Hepatol; 2013; 36(6):396-9. PubMed ID: 23587662
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Brodalumab.
    Gambardella A; Licata G; De Rosa A; Pagliuca F; Calabrese G; Alfano R; Argenziano G
    Dermatitis; 2021 Oct; 32(1S):e86-e88. PubMed ID: 33208631
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab.
    Yawalkar N; Hunger RE
    Dermatology; 2009; 218(1):79-83. PubMed ID: 18974629
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C.
    Warren RB; Al-Rifai A
    Br J Dermatol; 2013 Mar; 168(3):461-2. PubMed ID: 23445306
    [No Abstract]   [Full Text] [Related]  

  • 15. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ustekinumab for the treatment of HIV psoriasis.
    Paparizos V; Rallis E; Kirsten L; Kyriakis K
    J Dermatolog Treat; 2012 Dec; 23(6):398-9. PubMed ID: 21787206
    [No Abstract]   [Full Text] [Related]  

  • 17. Mild therapeutic response of alopecia areata during treatment of psoriasis with secukinumab.
    Pagnanelli G; Cavani A; Canzona F; Mazzanti C
    Eur J Dermatol; 2020 Oct; 30(5):602-603. PubMed ID: 33185532
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriatic Arthritis with Annular Pustular Psoriasis.
    Nagafuchi H; Watanabe K; Mikage H; Ozaki S
    Intern Med; 2016; 55(5):519-21. PubMed ID: 26935375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of psoriasis/psoriatic arthritis with inflammatory bowel disease influences management strategy.
    Shaw CA; Kole LCS; Elewski BE
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):e431-e432. PubMed ID: 31220373
    [No Abstract]   [Full Text] [Related]  

  • 20. Three cases of facial erythema with dryness and pruritus in psoriasis patients during treatment with IL-17 inhibitors.
    Oiwa T; Honda T; Otsuka A; Kabashima K
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):e122-e123. PubMed ID: 28983980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.